- Instructions for Authors
- ISSN 2576-2818 (online)
- Open access · CC BY 4.0
Instructions for Authors
This page explains how to prepare a manuscript for the Journal of Fertility Biomarkers. Complete information helps editors and reviewers evaluate the work.
Routes and review
- Primary route: ManuscriptZone, the publisher's online submission system.
- Alternative route: the simple manuscript submission form, which opens with this journal selected.
- Assisted route: the editorial office at info@openaccesspub.org, for authors who cannot use either online route.
Authors must use only one submission route for the same manuscript.
All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review. Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.
For double-blind review, remove author names, affiliations, acknowledgments, funding details, institution names, and other identifying information from the reviewer manuscript. Provide identifying information separately in the title-page file or submission form.
The article processing charge is payable only after acceptance; withdrawal after submission is subject to the journal's withdrawal policy. Fee-relief inquiries are considered case by case; contact the editorial office before or at submission.
Preparing each type
There are no fixed length limits for any article type; manuscripts should be concise and proportionate to their content. Hypotheses, methods, statistics, reporting checklists and the full section structure apply where they are relevant to the type. Validation, cohort and diagnostic-accuracy studies are prepared as Original Research, and a case series as a Case Report.
- Original Research
Abstract; Introduction stating the question or hypothesis; Methods; Results; Discussion; Conclusions. The study population or animal model, specimen collection and handling, assay methods, and the criteria used to define each marker and outcome are described so that the work can be repeated.
- Review
Abstract and a logically organized narrative that defines the topic, synthesizes the evidence critically and identifies gaps. The approach to selecting literature is stated. Systematic reviews and meta-analyses report databases, search strategy, eligibility criteria, selection, appraisal and synthesis, follow PRISMA, and report a protocol registration where one exists.
- Methods or Technical Note
Rationale, a step-by-step description with materials, evidence of performance such as precision, accuracy or comparison with a reference method, limitations, and the situations in which the method applies.
- Short Communication
A brief report of a complete, focused finding, with abstract, brief methods, results and discussion.
- Data Note
A description of a dataset: how it was collected, its structure and format, quality control, and its potential reuse, with a link to the repository record.
- Case Report
A patient, animal or event of wider interest, with background, case description, outcome and lessons. Case series are reported in this format.
- Commentary
A reasoned viewpoint with a clear argument, supported by cited evidence, on research, clinical practice or policy.
- Letter
A brief, evidence-based response to a published article, or a short report of a timely finding.
- Editorial
A piece written by the editors or by authors invited by the editors.
Files and structure
Title page
Title, authors with affiliations, ORCID iDs (recommended), the corresponding author's contact details, and a short running title.
Abstract and keywords
An abstract that states the purpose, approach, main results and conclusions, followed by keywords that identify the marker, the population or species and the topic. The abstract is structured where the article type calls for it, and is unstructured for narrative reviews, Commentaries and Letters.
Text
Manuscripts are submitted as editable Word or LaTeX files. Number the pages, define abbreviations at first use, and use SI units. Report the units and the assay platform for each laboratory measurement, and give the gene and protein nomenclature used. Sequences and expression data are deposited in a public database with the accession number reported.
Specimens and assays
Describe the specimen type, timing in relation to the menstrual or treatment cycle where relevant, collection, processing and storage, the assay and its manufacturer or method, and quality-control measures such as precision, calibration and limits of detection. For markers used to classify or predict, state how cutoffs were chosen and whether they were validated in an independent sample.
Figures and tables
Figures are supplied as separate image files at a resolution sufficient for legible reproduction, with captions that make each figure understandable on its own. Tables are editable text, not images, with clear headings and units, and each figure and table is cited in the text.
Statistics
Describe the unit of analysis, sample-size reasoning where applicable, handling of missing data and multiple comparisons, and the statistical tests. Report effect sizes and measures of uncertainty, such as confidence intervals, rather than p-values alone. Studies of diagnostic or prognostic performance report sensitivity, specificity, predictive values or discrimination and calibration, with confidence intervals.
Supplementary files
Supplementary material is supplied in final form, in open formats where possible, and is cited in the text. Authors obtain permission for reused material.
Approvals, data and disclosures
- Human participants and samples. Report ethics approval and informed consent, or a documented decision of the ethics committee on consent, where applicable, and how samples were obtained.
- Animal research. Report approval from an institutional animal ethics committee, the welfare measures used, and the ARRIVE items where applicable.
- Clinical trials. Interventional clinical trials must be registered in an accepted public trial registry at or before the first participant provides consent for enrollment. The registry name, registration number, and registration date must be reported in the manuscript.
- Data availability. Every empirical research manuscript must include a data-availability statement. See Data Archiving and Permissions.
- Use of AI. Disclose any use of AI tools in the manuscript, naming the tool and its purpose. AI tools are not authors.
- Declarations. Author contributions, funding, conflicts of interest, including any commercial interest in an assay or device under evaluation, and acknowledgments.
- Preprints. Preprints are allowed; give the server and identifier in the cover letter.
- License. Articles are published under CC BY 4.0 and authors retain copyright.
| Study design | Guideline |
|---|---|
| Animal experiments | ARRIVE |
| Diagnostic accuracy studies | STARD |
| Prognostic marker studies | REMARK |
| Observational studies | STROBE |
| Randomized trials | CONSORT |
| Systematic reviews and meta-analyses | PRISMA |
| Case reports | CARE |
| Quantitative PCR experiments | MIQE |
| Human biospecimens | BRISQ |
Field-specific checklists may be used where they apply. Guidelines are required where applicable to the design.
Citing sources
Cite sources in the text and list them in one consistent style. Include a DOI or stable URL when one exists.
- Article: Surname AB, Surname CD. Title of the article. Journal Name. Year;Volume(Issue):Pages. https://doi.org/xxxx
- Book: Surname AB. Title of the book. Edition. City: Publisher; Year.
- Webpage: Organization. Title of the page. Site name. Year. URL. Accessed date.
- Dataset: Surname AB. Title of the dataset. Repository name. Year. https://doi.org/xxxx
- Preprint: Surname AB. Title of the preprint. Preprint server. Year. https://doi.org/xxxx
- Trial registration: Registry name. Registration number. Title. Registration date. URL.
Submission checklist
- The work is within the Aims and Scope and prepared as one of these types: Original Research; Review (including Systematic Review and Meta-Analysis); Methods or Technical Note; Short Communication; Data Note; Case Report; Commentary; Letter; Editorial.
- Title page, abstract, keywords and main text follow the structure for the type.
- Ethics approvals, consent or a documented decision on consent, animal approvals and trial registration are reported where applicable.
- Specimen and assay details, the reporting-guideline checklist and the data-availability statement are included.
- Declarations are complete, including funding, conflicts of interest and any use of AI tools.
- Figures, tables, supplementary files and reused-material permissions are in final form.
- For a double-blind request, the reviewer manuscript is anonymized.
Submit your manuscript
Authors must use only one submission route for the same manuscript.